Search Results

ADVANCES IN AMD RESEARCH: HIGHLIGHTS FROM VIEW POINT

This February we recognized Age-Related Macular Degeneration (AMD) Awareness Month with a special View Point. Our expert panel discussed geographic atrophy (GA), new research on a potential antibody treatment, biosimilars and more....

OPTOGENETIC THERAPY TO TREAT VISION LOSS

Optogenetic therapy uses gene editing to add light-sensing molecules to cells. These cells can then be turned on and off by light. This technique has been used in research for many years...

BREAKING NEWS … CANADIANS ONE STEP CLOSER TO LUXTURNA GENE THERAPY ACCESS

Fighting Blindness Canada is excited to announce that Canadians are one step closer to being able to access voretigene neparvovec (Luxturna), the first gene therapy for an inherited retinal disease. As of...

DEVELOPING A STEM CELL THERAPY TO RESTORE SIGHT

Fighting Blindness Canada is pleased to announce that the team of Dr. David Gamm (University of Wisconsin) and Dr. William Beltran (University of Pennsylvania) have been awarded $725,000 to continue their ground-breaking...

HEALTH INFORMATION LINE

Getting diagnosed with an eye disease and navigating tests, appointments, and treatments can be confusing and complicated. Fighting Blindness Canada’s (FBC) Health Information Line is here to answer your eye health-related questions....

CORPORATE PARTNERS

Fighting Blindness Canada’s (FBC) corporate partners and sponsors help us fund innovative treatments and cures for 1.2 million Canadians living with vision loss, as well as national education programs bringing awareness to...